Zacks Research Issues Positive Outlook for Exelixis Earnings
Exelixis, Inc. (NASDAQ:EXEL – Free Report) – Equities researchers at Zacks Research lifted their FY2027 EPS estimates for Exelixis in a note issued to investors on Thursday, September 3rd. Zacks Research analyst Team now expects that the biotechnology company will post earnings per share of $3.59 for the year, up from their previous forecast of […]
9 Sep 05:12 · The Markets Daily